The LLS – Snowdome Foundation Translational Research Program funds new and innovative research that shows high promise for translating basic biomedical knowledge to clinical application.
Grants
Through the incredible generosity of our philanthropic donors and partners, the Snowdome Foundation can provide Australia’s best clinicians and researchers with much-needed funding to support their work.
Snowdome’s granting process identifies key strategic priorities in blood cancer research, including:
- Advancing innovation through translational research, clinical trials, emerging blood cancer research, novel treatment platforms or therapies
- New innovations in genomic and molecular profiling including translational and functional genomics
- Targeted and cellular therapies and their derivatives
- Precision medicine
To receive notifications of grant calls, please send your details to grants@snowdome.org.au
The Gunn Family Haematology Fellowship 2024
Snowdome is inviting applications in multiple myeloma that focuses on CAR T-cell therapy.